Novartis
NVS
NVS
1,093 hedge funds and large institutions have $23.5B invested in Novartis in 2019 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 180 increasing their positions, 852 reducing their positions, and 84 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,093
Holders Change
-39
Holders Change %
-3.45%
% of All Funds
23.78%
Holding in Top 10
29
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-25.64%
% of All Funds
0.63%
New
61
Increased
180
Reduced
852
Closed
84
Calls
$228M
Puts
$120M
Net Calls
+$108M
Net Calls Change
+$57.2M
Top Buyers
| 1 |
BCPEMI
Bain Capital Public Equity Management II
Boston,
Massachusetts
|
+$89.9M |
| 2 |
Renaissance Technologies
New York
|
+$44M |
| 3 |
SC
Samlyn Capital
New York
|
+$39.5M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$35.6M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$33.6M |
Top Sellers
| 1 |
Dodge & Cox
San Francisco,
California
|
-$1.02B |
| 2 |
BlackRock
New York
|
-$578M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
-$300M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$220M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$201M |
